// App-Quantinova.ai

2610 : Phase 1 dose escalation study of copanlisib (BAY 80-6946) in combination with gemcitabine or gemcitabine-cisplatin in advanced cancer patients.

Researchers

Presenter

  • Richard D. Kim

Principal Investigators

  • Steven R. Alberts

  • Jennifer Kaplan

  • Juneko E. Grilley-Olson

  • Frank Gary Renshaw

  • Isabelle Genvresse

  • Stefanie Reif

Medical Centers

  • Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, NC

  • H. Lee Moffitt Cancer Center & Research Institute, Tampa, FLMayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • BAY 80-6946

  • Gemcitabine

  • Copanlisib

  • Cisplatin

Outcome

  • Positive

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT01460537

Sponsors

  • Bayer

  • Bayer

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved